XCUR
Exicure, Inc.
$1.90
-0.09 (-4.52%)
At close · Jul 7
Going-concern doubt
— flagged May 29, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our ability to raise the additional capital that is needed to fund our operations and our pursuit of strategic alternatives, particularly given our current lack of a revenue source and the substantial doubt about our ability to continue as a going concern”View the 10-Q filed May 29, 2026
Market Cap
$12.11M
Shares
6,373,937
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.90
Open$2.01
Day$1.89–2.04
52W$1.71–9.50
Avg vol 30d36K
Short int15K · 0.2% float · 1.0d
Short vol5%
Last earningsMar 25, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 29
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−54%
below
Price vs 50-day avg
−34%
below
RSI (14)
31
neutral
MACD trend
Negative
52-week position
2%
near low
Momentum
relative strength
1-month return
−35%
trailing
6-month return
−67%
trailing
YTD return
−65%
this year
Relative strength
−75%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+20% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.23% of float · ▼ -29.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
18 holders — near 1-yr high, broad support
Squeeze score
37
low risk · 0–100
Fundamentals
Revenue growth
−100%
Y/Y
EPS growth
+83%
Y/Y
Free cash flow
$-8.6M
Balance sheet
$5.6M
net cash
Quant / Vol
risk profile
Volatility
112%
annualized · 1-yr
Max drawdown
−79%
past year
ATR
16.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice.
Up next
Next earnings call
Aug 3, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 29, 2026
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−54%
Bearish
Price vs 50-day avg
−34%
Bearish
RSI (14)
31
Neutral
MACD trend
Negative
Bearish
52-week position
2%
Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+20% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.23% of float · ▼ -29.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
18 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $2 · 2%
52-wk high $10
vs 200-day avg -54%
vs 50-day avg -34%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
XCUR
this stock
Exicure, Inc.
|
$12.11M | -64.9% | -100.0% | — | 0.2% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.55B | +15.2% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.49B | +9.4% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XCUR | -13.6% | -34.9% | -67.5% | -8.7% | -64.9% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -14.6% | -36.3% | -75.0% | -8.8% | -74.6% |